Besides, a recent study showed that gemcitabine could foster pyroptosis by activating the caspase-1/GSDMD pathway in PC, and pyroptosis activation by VbP, an enzymatic activator of caspase-1, confers PC gemcitabine sensitivity (43). Here, CASP1 is linked to pachyonychia congenita.